iDEND syndrome caused by KCNJ11 mutation unresponsive to sulfonylurea therapy: two case reports and literature review
Frontiers in Pediatrics · 05.11.2026 · 14
DOI: 10.3389/fped.2026.1973308 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pediatrics, online erschienen am 05.11.2026. Verfasst von Kunjiao Xue und 7 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Sichuan Provincial Science and Technology Support Program.
Abstract (Originalsprache)
Neonatal diabetes mellitus (NDM) is a rare monogenic form of diabetes that predominantly manifests within the first six months of life. This report presents two patients with mutations in the potassium inwardly rectifying channel subfamily J member 11 ( KCNJ11 ) gene, accompanied by a narrative literature review. Both infants exhibited severe diabetic ketoacidosis (DKA) and growth retardation, without seizures. Following ketoacidosis resolution, Patient 1 required continuous subcutaneous insulin infusion (CSII) with continuous glucose monitoring (CGM), while Patient 2 received hospital-based point-of-care testing-guided multiple daily insulin injections supplemented with glibenclamide. However, both cases exhibited persistent non-responsiveness to sulfonylurea therapy. Genetic testing revealed a heterozygous KCNJ11 c.497G > A (p.Cys166Tyr) variant in both infants. Based on their clinical manifestations, both patients were diagnosed with iDEND. This paper presents a comprehensive account of the clinical features, varied insulin delivery methods, and glucose monitoring strategies in two patients with iDEND harboring the KCNJ11 c.497G > A variant. This finding expands the known clinical spectrum associated with this specific variant and provides critical evidence-based guidance for the therapeutic management.
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- Sichuan Provincial Science and Technology Support Program
Zitieren
APA
Xue, K., Li, X., Zhang, T., Chen, C., Yuan, C., Liu, Y., Wu, J., & Lyu, J. (2026). iDEND syndrome caused by KCNJ11 mutation unresponsive to sulfonylurea therapy: two case reports and literature review. Frontiers in Pediatrics, 14. https://doi.org/10.3389/fped.2026.1973308
Vancouver
Xue K, Li X, Zhang T, Chen C, Yuan C, Liu Y, et al. iDEND syndrome caused by KCNJ11 mutation unresponsive to sulfonylurea therapy: two case reports and literature review. Frontiers in Pediatrics. 2026;14. doi:10.3389/fped.2026.1973308
BibTeX
@article{Xue2026,
author = {Xue, Kunjiao and Li, Xue and Zhang, Tingting and Chen, Congli and Yuan, Chuanjie and Liu, Ying and Wu, Jin and Lyu, Juanjuan},
title = {iDEND syndrome caused by KCNJ11 mutation unresponsive to sulfonylurea therapy: two case reports and literature review},
journal = {Frontiers in Pediatrics},
year = {2026},
volume = {14},
doi = {10.3389/fped.2026.1973308}
}
EUVIMED